View: Therapeutic Assays help


BioActivity Assays help :

# Assay ID Compound tested
active|inactive
Assay Title View Enriched Targets/Pathways
1 463187 1495|218839 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC view
2 540333 318|9922 A CPE Based HTS Assay for Antiviral Drug Screening Against Dengue Virus view
3 2391 409|308281 A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) view
4 588727 453|345569 A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83 view
5 1224888 410|8568 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour view
6 1224875 583|8310 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour view
7 1224881 709|8079 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour view
8 1224871 843|7906 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour view
9 1224884 327|8698 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour view
10 1224876 569|8375 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour view
11 1224878 762|7985 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour view
12 1224883 898|7768 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour view
13 1224879 1021|7612 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour view
14 1224890 389|8703 A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour view
15 624263 825|399891 A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression view
16 2315 26913|266718 A qHTS for Small Molecule Inhibitors of Shiga Toxin view
17 624296 9907|283848 A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. view
18 624297 6247|303474 A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. view
19 1053175 702|328474 A screen for compounds that inhibit growth of Escherichia coli view
20 493162 428|45289 A screen for compounds that inhibit processive DNA synthesis of vaccinia virus view
21 504770 352|132381 A screen for compounds that inhibit replication of Vibrio cholerae chromosome II view
22 492967 320|139137 A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis view
23 540299 440|102718 A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis view
24 720641 901|167898 A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus view
25 493033 931|103822 A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI view
26 588519 1006|151507 A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities view
27 588478 1078|329843 A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37 view
28 1863 476|300328 A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium view
29 1850 1021|305403 A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi view
30 2690 590|328352 A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide view
31 623870 2595|390300 ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity view
32 602163 1074|361276 Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA) view
33 651718 2709|360167 Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA) view
34 435030 937|325198 Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex view
35 651602 953|361923 Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage) view
36 463141 350|325785 Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3 view
37 493131 3331|333021 Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity view
38 493208 342|41294 Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon view
39 504660 3724|360902 Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS view
40 641 3414|54294 Allosteric Modulators of D1 Receptors: Primary Screen view
41 504652 11466|347567 Antagonist of Human D 1 Dopamine Receptor: qHTS view
42 504810 674|328288 Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign view
43 504621 972|306259 Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2 view
44 1251 716|194772 Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen view
45 1996 40286|17573 Aqueous Solubility from MLSMR Stock Solutions view
46 504490 1061|337539 Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling view
47 624465 302|357179 Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists view
48 624463 1056|359564 Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists view
49 624464 808|355261 Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators view
50 720647 1340|376166 Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition view
51 504423 262|336474 C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity view
52 652162 840|352012 C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity view
53 778 20295|75571 CYP2C19 Assay view
54 777 18731|77136 CYP2C9 Assay view
55 463 706|55782 Cell Proliferation & view
56 662 1760|50761 Cell signaling CRE-BLA (Fsk stim) view
57 1362 4012|190222 Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen view
58 588436 553|349762 Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity view
59 2071 1717|278430 Colorimetric Assay for Inhibitors for NALP1 view
60 1020 236|195397 Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay view
61 1006 2978|192655 Counter Screen for Luciferase-based Primary Inhibition Assays view
62 1379 565|199588 Counterscreen for Luciferase (Kinase-Glo TM) Inhibition view
63 2797 815|324042 Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) view
64 2174 499|314601 Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). view
65 2177 1197|313903 Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). view
66 504692 2039|333422 Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) view
67 687016 2779|367495 Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide view
68 449728 894|325241 Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability view
69 2234 485|314615 Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA. view
70 1486 2420|215696 Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability. view
71 2235 2846|312254 Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). view
72 588335 4455|351951 Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts view
73 652141 4492|1078 Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts view
74 504634 279|335182 Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) view
75 463210 302|325833 Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7 view
76 624483 10932|336266 Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease view
77 1463 2576|251621 Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization view
78 2314 37055|259390 Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin view
79 651640 5952|324821 DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity view
80 743445 1662|308169 Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_SinglePoint_HTS_Activity_Set2 view
81 626 1938|61743 Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist Primary Screen view
82 504329 1013|334345 Discovery of Small Molecule Probes for H1N1 Influenza NS1A view
83 628 2180|61481 Discovery of novel allosteric modulators of the M1 muscarinic receptor: Antagonist Primary Screen view
84 624330 2057|338351 Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens view
85 504441 1321|308882 Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity view
86 1230 220|207677 E3 Ligase HTS_1536 view
87 651548 201|57001 EZH2/PRC2 methyltransferase inhibitors Measured in Biochemical System Using Plate Reader - 2125-01_Inhibitor_SinglePoint_HTS_Activity view
88 488890 1277|312390 Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis view
89 720702 1243|369031 Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2) view
90 1556 1322|289570 Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase view
91 651710 1634|354226 FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 view
92 485270 5750|320385 FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R view
93 800 649|216852 Factor XIIa 1536 HTS view
94 798 302|218481 Factor XIa 1536 HTS view
95 602162 692|361545 Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set view
96 651702 2404|361030 Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library view
97 2099 228|326540 Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity view
98 624156 901|44624 Fluorescence Cell-Based Primary HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity view
99 1979 1737|295157 Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound view
100 2718 485|313901 Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3 view
101 2216 3282|282391 Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex view
102 2563 800|293441 Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of the Ras-converting Enzyme view
103 2221 2198|291260 Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity view
104 652039 3330|365913 Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen view
105 2629 1947|321927 Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction view
106 602252 2737|293918 Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity view
107 619 518|96590 Fluorescence polarization assay for PLK1 inhibitors view
108 687043 253|15744 Fluorescence polarization based primary biochemical high throughput screening assay of ChemBridge compounds to identify inhibitors of hepatitis C virus non-structural protein 3 helicase view
109 588549 777|353631 Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity view
110 504523 489|336339 Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity view
111 720543 2015|368259 Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4). view
112 1053197 2555|367699 Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE) view
113 504707 285|343415 Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex view
114 504700 273|343427 Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex view
115 651572 954|361884 Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) view
116 624377 680|362196 Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) view
117 720509 761|369513 Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )] view
118 720508 498|369776 Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )] view
119 493087 245|335216 Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) view
120 434962 1316|323541 Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) view
121 1974 3207|299547 Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). view
122 1947 993|301761 Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B. view
123 602123 1524|360820 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) view
124 2280 1420|323436 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. view
125 485272 1334|324799 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) view
126 2130 1683|313417 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). view
127 492956 3326|332135 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2) view
128 492972 930|334531 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) view
129 492953 4161|331300 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) view
130 2057 2141|312958 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. view
131 1962 2452|300302 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2&apos view
132 1950 1022|301732 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1). view
133 504803 1713|341986 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) view
134 463082 4934|321201 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) view
135 2751 2222|322635 Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL) view
136 651616 4366|1204 Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis view
137 1117264 439|88733 Fluorescence-based biochemical high throughput primary assay to identify inhibitors of Trypanosoma brucei RNA editing ligase 1 (TbREL1) view
138 720704 662|369612 Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3). view
139 720700 3123|367151 Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1). view
140 651958 2045|367198 Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate view
141 651800 1344|361529 Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe view
142 493008 801|334660 Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) view
143 493244 390|335070 Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) view
144 588726 8221|351262 Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis view
145 651821 4670|364573 Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats view
146 588814 1190|358293 Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) view
147 624127 503|363627 Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) view
148 624037 699|363431 Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) view
149 624467 3577|359299 Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) view
150 651719 1564|356555 Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) view
151 588852 4560|354923 Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) view
152 624125 2640|361490 Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) view
153 624040 2140|361990 Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) view
154 624466 5386|357490 Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) view
155 434989 1389|324746 Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R view
156 504734 734|342966 Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. view
157 624267 1387|362743 Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) view
158 588819 316|359167 Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1). view
159 624126 1450|362680 Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) view
160 624038 1081|363049 Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) view
161 720488 959|15038 Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of a ChemBridge library: biochemical high-throughput screening assay to identify compounds that cause fluorescent interference view
162 1845 487|290404 Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) view
163 463079 2041|324094 Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line view
164 1987 564|314536 Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5). view
165 504411 203|343497 Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB) view
166 1800 1636|289256 Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) view
167 2435 1044|323813 Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR). view
168 1861 3132|287760 Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7). view
169 488965 213|337470 Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity view
170 430 1123|61538 Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells) view
171 431 1068|61592 Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells) view
172 620 364|86393 Fluorescent HTS Cytotoxicity/Cell viability assay (HT1080 cells) view
173 602248 1732|360618 Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line view
174 602250 2170|360180 Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line view
175 360 549|45736 Glucocerebrosidase view
176 2205 1625|194227 HCS assay for microtubule stabilizers view
177 1628 927|190531 HCS for Compounds that Down-Regulate Insulin Promoter Activity in MIN6 Cells view
178 1625 574|191406 HCS for Compounds that Up-Regulate Insulin Promoter Activity in MIN6 Cells view
179 1381 1035|218979 HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules. view
180 651610 3870|350497 HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity view
181 372 770|99067 HIV-1 RNase H Inhibition view
182 565 1250|63988 HIV-1 RT-RNase H MLSCN HTS MH077605 view
183 1024 1368|94499 HTS Assay for Activators of Cytochrome P450 2A9 view
184 485358 1780|336495 HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists view
185 485344 6869|292814 HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists view
186 540275 617|297003 HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 view
187 651550 1139|355285 HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen view
188 588405 6155|353365 HTS Assay for Peg3 Promoter Inhibitors view
189 485347 1178|341505 HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators view
190 1992 347|49487 HTS Colorimetric assay for the identification of compounds that inhibit VHR1 view
191 521 727|113651 HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target view
192 2540 4122|326357 HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8) view
193 1430 239|220095 HTS assay for inhibitors of Trypanosoma brucei hexokinase 1 view
194 422 314|163541 HTS for 14-3-3 protein interaction modulators view
195 436 346|71189 HTS for BAP1 Enzyme inhibitors view
196 720706 5501|345724 HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity view
197 504454 1446|338077 HTS for Beta-2AR agonists via FAP method view
198 633 1114|84991 HTS for Estrogen Receptor-beta Coactivator Binding inhibitors view
199 2557 646|326353 HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library view
200 743397 328|335314 HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity view
201 540317 2150|371461 HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails view
202 652154 4161|352055 HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity view
203 429 223|63693 HTS for Tumor Hsp90 Inhibitors view
204 2052 221|326160 HTS for developing T Cell Immune Modulators view
205 2732 8242|210921 HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress view
206 602340 2587|328400 HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity view
207 651654 735|360260 HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity view
208 1216 656|193569 HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat view
209 1220 1288|192937 HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate view
210 1209 814|193411 HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. view
211 1497 501|92021 HTS identification of compounds inhibiting the binding of CD11b/CD18 to fibrinogen via a luminescence assay. view
212 639 1151|84954 HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators view
213 629 1442|84663 HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors view
214 630 251|87809 HTS of Smad transcription factor inhibitors view
215 504577 1287|344935 HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin view
216 588358 1495|306992 HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies view
217 624256 3725|348601 HTS to identify compounds that promote myeloid differentiation with MLPCN compound set view
218 1377 832|216377 HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells. view
219 761 398|190111 HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype view
220 760 365|190143 HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype view
221 764 219|190281 HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant view
222 757 521|189985 HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype view
223 759 267|190240 HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype view
224 504775 306|316463 HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity view
225 488896 3066|315854 HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity view
226 485317 10859|276673 HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS view
227 504408 5173|294800 Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity view
228 2417 4337|106428 High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment view
229 1665 587|193018 High Throughput Imaging Assay for Beta-Catenin view
230 1656 954|235203 High Throughput Imaging Assay for Hepatic Lipid Droplet Formation view
231 1949 1594|95927 High Throughput Screen of 100,000 compound library to Identify Inhibitors of Mycobacterium tuberculosis H37Rv view
232 2842 1248|22216 High Throughput Screen of a Putative Kinase Compound Library to Identify Inhibitors of Mycobacterium tuberculosis H37Rv view
233 1066 792|193626 High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases - Primary Screen view
234 827 1659|136778 High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor view
235 818 2052|136705 High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression view
236 1239 3101|190194 High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen view
237 1117319 1501|248800 High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction view
238 1626 2044|209842 High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv view
239 449762 1938|312997 High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media view
240 449768 1416|107002 High Throughput Screening for Cocaine Antagonists: Primary Screen view
241 1159524 5052|370889 High Throughput Screening for Foot and Mouth Disease Virus Antivirals view
242 1918 2464|122832 High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen view
243 2550 383|305295 High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6) view
244 2553 3255|302423 High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6) view
245 651819 1085|361501 High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity view
246 463193 1904|192540 High-content cell-based screening for modulators of autophagy view
247 588499 612|348277 High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set view
248 588497 780|339860 High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set view
249 588501 425|352776 High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set view
250 1325 200|194279 High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen view
251 2073 567|288507 Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay view
252 648 925|85244 Human Endothelial Cell Proliferation Assay in 384-well format view
253 580 338|9364 Human H69AR Lung Tumor Cell Growth Inhibition Assay view
254 598 5141|80068 Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen view
255 719 937|83952 Human Lung Fibroblast Proliferation Assay view
256 796 409|93762 IL-1B Induced NFkB Translocation - Primary Screen view
257 817 295|138462 Identification and characterization of compounds for addressing human bone marrow failure view
258 799 843|137894 Identification of Molecular Probes that Activate MRP-1 view
259 1456 4127|185147 Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen view
260 1903 1204|303210 Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents view
261 720511 1253|346502 Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity view
262 602346 1162|332669 Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity view
263 686992 963|258274 Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity view
264 602329 506|360687 Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity view
265 1224865 1100|363066 Identify inhibitors of HNF4 alpha protein binding to DNA view
266 493036 557|331302 Image-Based HTS for Selective Agonists for NTR1 view
267 2013 370|291177 Image-Based HTS for Selective Antagonists for GPR55 view
268 504582 2306|332936 In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity view
269 743247 297|345074 Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity view
270 2303 2009|11305 Inhibition of HepG2 cell line view
271 2302 7952|5481 Inhibition of P. falciparum Dd2 view
272 651739 4051|1326 Inhibition of T.cruzi proliferation in culture Measured in Cell-Based System Using Plate Reader - 2138-01_Inhibitor_SinglePoint_CherryPick_Activity view
273 651740 1197|4248 Inhibition of T.cruzi proliferation in culture Measured in Cell-Based System Using Plate Reader - 2138-01_Inhibitor_SinglePoint_CherryPick_Activity_Set2 view
274 624255 4591|71598 Inhibition of T.cruzi proliferation in culture Measured in Cell-Based System Using Plate Reader - 2138-01_Inhibitor_SinglePoint_HTS_Activity view
275 651704 1633|345070 Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity view
276 449739 4230|100511 Inhibitors of Cav3 T-type Calcium Channels: Primary Screen view
277 504558 2374|342658 Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity view
278 1376 533|215579 Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU) view
279 1445 913|215333 Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP) view
280 1619 827|216208 Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP) view
281 488862 1169|333842 Inhibitors of Prion Protein 5&apos view
282 504865 358|6634 Inhibitors of USP1/UAF1: Pilot qHTS view
283 743255 906|372568 Inhibitors of USP1/UAF1: Primary Screen view
284 504884 229|355847 Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity view
285 1422 1316|255421 Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen view
286 504847 3730|384179 Inhibitors of the vitamin D receptor (VDR): qHTS view
287 651903 1092|21094 Intracellular Trypanosomes Measured in Cell-Based/Microorganism System Using Plate Reader - 2017-01_Inhibitor_SinglePoint_HTS_Activity_Set2 view
288 504812 674|328288 Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign view
289 645 448|64192 Isolation of Inhibitors of Her-Kinase Expression - 66K library screen view
290 873 1264|212996 Kallikrein 5 1536 HTS view
291 1063 17630|178542 Leishmania major promastigote HTS view
292 588692 830|356987 Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 view
293 2716 3324|315445 Luminescence Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301 view
294 2462 216|323319 Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis. view
295 435005 2443|301016 Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. view
296 2717 3190|297010 Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells view
297 2098 2328|298614 Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). view
298 2330 2816|34119 Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33 view
299 2313 458|20860 Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway view
300 624151 414|27150 Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity view
301 1910 950|299206 Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway view
302 651661 2325|343544 Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity view
303 1885 4396|297960 Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication view
304 2650 318|315188 Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha view
305 2661 235|321672 Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity view
306 624268 1456|362674 Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) view
307 602281 2853|361277 Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP view
308 602229 1282|361068 Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) view
309 652010 4096|365147 Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1 view
310 1117267 1155|90787 Luminescence-based cell-based primary high throughput screening assay to identify activators of Transthyretin (TTR) transcription view
311 652067 5354|364920 Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) view
312 652126 3700|366574 Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) view
313 540364 1985|354421 Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter view
314 652017 3838|365405 Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) view
315 504326 993|334468 Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors view
316 687014 6840|363434 Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12). view
317 624169 2415|361715 Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) view
318 540308 3476|352930 Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R view
319 686940 2610|367664 Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) view
320 588354 428|359054 Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1 view
321 651957 620|368623 Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2 view
322 588352 621|358862 Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3 view
323 504357 697|334764 Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors view
324 602396 460|363670 Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1 view
325 1825 2264|288628 Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line. view
326 1789 2651|288241 Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) view
327 2796 7990|316867 Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) view
328 504766 3418|340282 Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1 view
329 743287 2292|371892 Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity view
330 618 537|86212 Luminescent HTS for small molecule inhibitors of MT1-MMP transcription view
331 696 1178|94560 Luminescent assay for HTS discovery of chemical activators of placental alkaline phosphatase view
332 1016 326|195318 Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase view
333 588334 2272|297890 MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity view
334 488899 2767|328648 MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity view
335 1814 21692|277104 MLPCN Alpha-Synuclein 5&apos view
336 1813 2501|300874 MLPCN Alpha-Synuclein 5&apos view
337 652197 500|338613 MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity view
338 651723 741|347947 MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity view
339 651687 603|347393 MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity view
340 1663 661|301071 MLPCN Platelet Activation -Dense Granule Release view
341 1554 517|302824 MLPCN Ras selective lethality-BJeLR viability view
342 652115 3756|322845 MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 view
343 1662 3962|298787 MLPCN Streptokinase Expression Inhibition view
344 1832 1137|299850 MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen view
345 1051 335|99032 Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) view
346 1049 782|195472 Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) view
347 1048 390|98977 Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) view
348 739 875|96643 Modulators of Post-Golgi Transport view
349 940 2162|259860 Modulators of the EP2 prostaglandin E2 receptor - Primary Screening view
350 1530 1006|288932 Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant view
351 1529 4159|285663 Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype view
352 1531 3285|286415 Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype view
353 2029 210|318246 Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. view
354 2023 1091|322444 Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. view
355 2016 1682|323708 Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. view
356 2025 982|323142 Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. view
357 1008 237|194167 Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1 view
358 1441 826|217646 Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. view
359 1415 711|217789 Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. view
360 1439 770|183960 Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao. view
361 1423 750|217727 Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao. view
362 602481 342|356100 Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity view
363 179 1549|40601 NCI AIDS Antiviral Assay view
364 192 500|4708 NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice view
365 248 1602|53818 NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice view
366 256 1040|18275 NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice view
367 328 1574|9217 NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice view
368 330 2467|39943 NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice view
369 167 9708|72154 NCI Yeast Anticancer Drug Screen. Data for the bub3 strain view
370 165 8161|73695 NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain view
371 157 8920|73597 NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain view
372 175 10273|72222 NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain view
373 155 9907|72610 NCI Yeast Anticancer Drug Screen. Data for the rad50 strain view
374 161 9646|72210 NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain view
375 137 2174|38180 NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line view
376 129 1679|33766 NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line view
377 19 2047|39451 NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line view
378 139 2093|38519 NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line view
379 89 1296|23916 NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line view
380 131 2129|36269 NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line view
381 119 3631|35590 NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line view
382 67 2194|38609 NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line view
383 69 787|13266 NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line view
384 63 962|13345 NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line view
385 61 920|12300 NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line view
386 43 1553|26531 NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line view
387 21 1501|38679 NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line view
388 77 1882|34881 NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line view
389 79 2565|38328 NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line view
390 71 2168|38663 NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line view
391 125 3438|33901 NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line view
392 11 614|10377 NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line view
393 9 1934|38000 NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line view
394 13 2007|34054 NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line view
395 97 1478|24944 NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line view
396 65 2193|38919 NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line view
397 101 2110|38684 NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line view
398 121 3001|37290 NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line view
399 73 2074|38851 NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line view
400 75 710|13022 NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line view
401 23 2571|35928 NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line view
402 17 739|12669 NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line view
403 25 2017|38492 NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line view
404 27 815|13766 NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line view
405 29 2032|36343 NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line view
406 83 2381|26079 NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line view
407 95 1468|26243 NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line view
408 85 1883|26378 NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line view
409 87 1837|25839 NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line view
410 123 3236|37387 NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line view
411 3 1877|35924 NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line view
412 1 2124|39103 NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line view
413 5 1602|38199 NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line view
414 7 2447|37447 NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line view
415 15 2791|34496 NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line view
416 93 1486|27059 NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line view
417 99 2171|37782 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line view
418 105 1581|37559 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line view
419 107 1357|38818 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line view
420 109 2154|39245 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line view
421 41 1642|26558 NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line view
422 113 2789|35357 NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line view
423 133 2086|34445 NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line view
424 135 507|10293 NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line view
425 45 2081|38638 NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line view
426 47 2103|39046 NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line view
427 49 2148|36319 NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line view
428 35 1659|36820 NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line view
429 39 1509|39048 NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line view
430 37 2280|37986 NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line view
431 103 1587|37373 NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line view
432 145 2029|38851 NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line view
433 53 1758|38928 NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line view
434 55 2126|35978 NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line view
435 57 604|12798 NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line view
436 115 3367|30396 NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line view
437 81 2497|38924 NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line view
438 91 1571|24901 NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line view
439 141 1333|38603 NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line view
440 59 2247|38955 NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line view
441 33 1710|39163 NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line view
442 31 2217|38069 NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line view
443 143 1944|38578 NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line view
444 51 798|10984 NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line view
445 624139 218|16738 NF-KappaB Measured in Biochemical System Using Small Molecule MicroArray - 2080-01_Other_SinglePoint_HTS_Activity view
446 444 204|8067 NFAT Signaling Pathway view
447 651742 782|4656 NIH/3T3 (mouse embryonic fibroblast) toxicity Measured in Cell-Based System Using Plate Reader - 2138-02_Inhibitor_SinglePoint_CherryPick_Activity view
448 651744 3109|2307 NIH/3T3 (mouse embryonic fibroblast) toxicity Measured in Cell-Based System Using Plate Reader - 2138-02_Inhibitor_SinglePoint_CherryPick_Activity_Set2 view
449 841 2077|135720 Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library) view
450 602156 275|5422 Novartis GNF Liver Stage Dataset: Malariabox Annotation view
451 602277 265|9728 Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus view
452 707 310|90338 Novel sEH inhibitors for the therapeutic treatment of hypertension and inflammation view
453 504444 7472|285611 Nrf2 qHTS screen for inhibitors view
454 504648 611|371372 Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity view
455 1154 1142|4187 PSACAntagonistScreen(Absorb.700[IndoChina.Blood(.01h)]) view
456 1155 394|4935 PSACAntagonistScreen(Absorb.700[IndoChina.Blood(.02h)]) view
457 602405 350|358445 PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity view
458 485275 1437|327572 Phenotypic HTS multiplex for antifungal efflux pump inhibitors view
459 1159554 2149|91831 Plasmodium falciparum Dd2 Sybr green parasite growth Measured in Cell-Based and Microorganism Combination System Using Plate Reader view
460 2094 1222|300279 Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System view
461 573 1420|63699 Primary Antimicrobial Assay for E. coli BW25113 & view
462 574 446|64478 Primary Cell Based High Throughput Screening Assay for Agonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E) view
463 571 641|64283 Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E) view
464 1509 771|217345 Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) view
465 1510 569|217547 Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) view
466 729 447|96441 Primary Cell-Based High-Throughput Screening to Identify Agonists of the Sphingosine 1-phosphate receptor 2 (S1P2) view
467 736 207|96681 Primary Cell-Based High-Throughput Screening to Identify Antagonists of the Sphingosine 1-phosphate receptor 2 (S1P2) view
468 1321 2616|215500 Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation view
469 560 979|63945 Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) view
470 522 1225|63699 Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) view
471 561 278|64646 Primary Cell-based High Throughput Screening assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA) view
472 525 359|64565 Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1) view
473 485 462|168775 Primary HTS Assay for S1P3 Antagonists view
474 449 315|55411 Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators view
475 567 366|64558 Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) agonists view
476 612 416|61192 Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) antagonists view
477 1246 843|117189 Primary HTS assay for chemical inhibitors of TNF alpha stimulated E-Selectin expression view
478 802 457|93999 Primary HTS assay for chemical inhibitors of TNF alpha stimulated VCAM1 expression view
479 819 282|93289 Primary HTS assay for chemical potentiators of IL-1B stimulated NFkB nuclear translocation view
480 845 387|93853 Primary HTS assay to asses cytotoxicity for IL-1B stimulated NFkB expression. view
481 1053188 780|82225 Primary Screen Inhibitors of CD40 Signaling in BL2 Cells Measured in Cell-Based System Using Plate Reader - 7124-01_Inhibitor_SinglePoint_HTS_Activity view
482 588689 1013|336307 Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition view
483 631 811|195444 Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) view
484 1032 670|195584 Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) view
485 731 519|195736 Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) view
486 652257 4763|365511 Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) view
487 2129 2201|312898 Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). view
488 1515 445|217671 Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9) view
489 1527 2575|288317 Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase view
490 727 811|96077 Primary biochemical high-throughput screening assay for inhibitors of Focal Adhesion Kinase (FAK) view
491 604 212|59592 Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2) view
492 704 769|96119 Primary biochemical high-throughput screening assay for inhibitors of the HIV Rev RRE RNA interaction (disruption of protein-RNA interaction) view
493 746 366|59438 Primary biochemical high-throughput screening assay for inhibitors of the c-Jun N-Terminal Kinase 3 (JNK3) view
494 1481 925|217191 Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition view
495 793 1385|138723 Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2) view
496 1446 2401|215715 Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F view
497 1700 672|290220 Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5) view
498 932 5134|190877 Primary cell-based high throughput screening assay to measure STAT1 activation view
499 920 695|195316 Primary cell-based high throughput screening assay to measure STAT1 inhibition view
500 871 1773|192924 Primary cell-based high throughput screening assay to measure STAT3 activation view
501 862 1724|192973 Primary cell-based high throughput screening assay to measure STAT3 inhibition view
502 1040 1990|194264 Primary cell-based high-throughput screening assay for antagonists of NPY-Y1 view
503 2227 1291|304377 Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4) view
504 2642 3880|301798 Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels view
505 2156 3407|302270 Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels view
506 463165 1365|304313 Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) view
507 1672 2598|303080 Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 view
508 2239 1644|304024 Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels view
509 2648 1082|304596 Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels view
510 463111 2823|302855 Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) view
511 1511 1552|304126 Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents view
512 861 356|195655 Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding view
513 1304 800|217316 Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1 view
514 1359 971|217145 Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2 view
515 803 678|139430 Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2) view
516 1044 243|15756 Primary cell-based high-throughput screening assay to identify agonists of Sphingosine 1-Phosphate receptor 1 (S1P1) view
517 1448 632|217484 Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3) view
518 1424 390|217726 Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1) view
519 828 548|139560 Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2) view
520 1416 370|217746 Primary cell-based high-throughput screening assay to measure PERK inhibition view
521 588627 1352|305242 Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling view
522 623877 1022|334384 Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A) view
523 588675 1933|304661 Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling view
524 588676 3871|302723 Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling view
525 588511 3634|302960 Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) view
526 2237 1511|304157 Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4). view
527 488977 1511|305083 Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) view
528 488975 2634|303960 Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) view
529 602410 2843|337058 Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 view
530 488922 3799|301879 Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 view
531 2247 1189|302880 Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4). view
532 504832 18125|220630 Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation view
533 504834 22396|197740 Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation view
534 1276 1987|191469 Primary screen for compounds that activate Alzheimer&apos view
535 1296 1039|126117 Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells view
536 1285 1590|192180 Primary screen for compounds that inhibit Alzheimer&apos view
537 1273 1153|126162 Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells view
538 1775 825|216798 Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission view
539 1776 489|194272 Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission view
540 709 3590|61854 Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm view
541 585 1266|68769 Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) view
542 361 602|50027 Pyruvate Kinase view
543 743126 2090|368184 QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2) view
544 720582 2294|367980 QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10. view
545 720648 3080|367194 QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17. view
546 1906 1482|301272 QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1). view
547 1822 3501|287391 QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). view
548 1706 405|290487 QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro) view
549 1865 543|271137 Quantitative High-Throughput Screen for Regulators of Epigenetic Control view
550 488847 1924|326126 RNA aptamer-based HTS for inhibitors of GRK2 view
551 1532 417|105295 Rml C and D inhibition 384-well mixture HTS view
552 540336 521|326930 Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity view
553 652163 502|355308 S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity view
554 624137 362|31007 SMM ID4 Measured in Biochemical System Using Small Molecule MicroArray - 2128-01_Other_SinglePoint_HTS_Activity view
555 624141 257|16699 SMM c-myc Measured in Biochemical System Using Small Molecule MicroArray - 2081-01_Other_SinglePoint_HTS_Activity view
556 588674 1846|355142 Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 view
557 775 904|131891 Screen for Chemicals that Extend Yeast Lifespan view
558 868 3545|191036 Screen for Chemicals that Inhibit the RAM Network view
559 804 710|138047 Screen for Chemicals that Shorten Yeast Lifespan view
560 1159607 380|69514 Screen for inhibitors of RMI FANCM (MM2) intereaction view
561 602393 7048|338975 Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity view
562 434955 876|322806 Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics view
563 556 320|65089 Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC view
564 555 316|64949 Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK view
565 539 319|65097 Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK view
566 738 4851|92676 Screening for Modulators of Post-Golgi Transport, Control Strain view
567 504668 5683|559 Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. view
568 504607 4830|1412 Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay view
569 488918 3691|2505 Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay view
570 488919 2417|3779 Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Luminescent Interference Counterscreen assay view
571 463213 4140|3235 Single concentration confirmation of small molecule inhibitors of tim10-1 yeast via a luminescent assay view
572 489028 5580|4478 Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. view
573 488915 3568|2628 Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 6 (SENP6) using a Luminescent assay view
574 488917 4283|1913 Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 7 (SENP7) using a Luminescent assay view
575 488912 2491|3705 Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 8 (SENP8) using a Luminescent assay view
576 434970 311|10492 Single concentration confirmation of uHTS hits from a small molecule activators of mouse intestinal alkaline phosphatase via a luminescent assay view
577 434971 509|10294 Single concentration confirmation of uHTS hits from a small molecule inhibitors of mouse intestinal alkaline phosphatase via a luminescent assay view
578 624504 3944|1096 Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay view
579 651658 5128|337938 Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & view
580 540267 530|335561 Small Molecules that selectively kill Giardia lamblia: qHTS view
581 1159603 1004|6871 Small molecule combination matrix view
582 623901 472|335006 Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity view
583 602342 1023|334586 Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity view
584 2300 380|314719 TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3). view
585 1899 998|301756 TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization view
586 686964 1149|369125 TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide view
587 743269 2355|367919 TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration view
588 588664 1435|358048 TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) view
589 624416 1546|361330 TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9 view
590 540295 1704|354702 TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R view
591 720596 1597|368677 TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC) view
592 1159580 568|4938 The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395 view
593 1046 557|216692 Thrombin 1536 HTS view
594 1479 816|278249 Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 view
595 686996 1854|346135 VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2 view
596 2546 10659|271123 VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity view
597 602363 451|349399 Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity view
598 743398 3631|299930 Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity view
599 688 248|26940 Yeast eIF2B assay view
600 1090 220|5109 YeastGrowthModifierScreen2005(Absorb.600[Pombe972._Basal(.24h)]) view
601 898 223|139726 YopH HTS view
602 410 4439|4005 p450-cyp1a2 view
603 651965 6440|323409 qHTS Assay for Activators of ClpP view
604 1631 892|259865 qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase view
605 2242 715|183497 qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease view
606 2676 1093|360487 qHTS Assay for Agonists of the Relaxin Receptor RXFP1 view
607 926 352|56969 qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor view
608 938 1807|61597 qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 view
609 923 789|72992 qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region view
610 1461 2314|206429 qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction view
611 912 471|57097 qHTS Assay for Anthrax Lethal Toxin Internalization view
612 595 308|67116 qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction view
613 1458 5854|193074 qHTS Assay for Enhancers of SMN2 Splice Variant Expression view
614 485281 256|318888 qHTS Assay for Identification of Novel General Anesthetics view
615 914 223|7902 qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway view
616 915 455|7902 qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway view
617 485349 619|319803 qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia view
618 1457 727|205334 qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium view
619 1768 615|234146 qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide view
620 2100 1169|293743 qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen view
621 2101 299|314852 qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease view
622 899 1954|7032 qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19 view
623 883 1315|7577 qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9 view
624 891 1773|6809 qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6 view
625 884 3569|7626 qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 view
626 2147 3597|190727 qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) view
627 887 1044|69418 qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) view
628 881 602|104871 qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) view
629 1030 16112|148299 qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) view
630 504333 15779|312744 qHTS Assay for Inhibitors of BAZ2B view
631 1490 10947|287951 qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) view
632 2528 697|352269 qHTS Assay for Inhibitors of Bloom&apos view
633 485314 4522|315790 qHTS Assay for Inhibitors of DNA Polymerase Beta view
634 411 1577|70072 qHTS Assay for Inhibitors of Firefly Luciferase view
635 2451 2060|276148 qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia view
636 2472 1949|289484 qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen view
637 504327 817|376626 qHTS Assay for Inhibitors of GCN5L2 view
638 886 2511|65560 qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II) view
639 894 6494|126738 qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) view
640 893 5703|63810 qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 view
641 651820 11664|271341 qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) view
642 504332 31107|270503 qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a view
643 2326 1073|260684 qHTS Assay for Inhibitors of Influenza NS1 Protein Function view
644 504339 17026|342177 qHTS Assay for Inhibitors of JMJD2A-Tudor Domain view
645 1721 1089|290103 qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) view
646 588453 4036|373600 qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS view
647 880 1027|233096 qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) view
648 540253 242|325034 qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation view
649 2549 1295|234851 qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) view
650 485290 986|345634 qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) view
651 651724 1654|328375 qHTS Assay for Inhibitors of the CtBP/E1A Interaction view
652 1454 548|126843 qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay view
653 995 711|66041 qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay view
654 651644 751|354319 qHTS Assay for Inhibitors of the HIV-1 protein Vpr view
655 2517 1226|340061 qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) view
656 651725 2028|355074 qHTS Assay for Inhibitors of the Six1/Eya2 Interaction view
657 2685 2061|149192 qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells view
658 2289 3287|304503 qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21 view
659 485313 7586|304845 qHTS Assay for NPC1 Promoter Activators view
660 1478 860|195871 qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) view
661 1476 4521|169517 qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) view
662 485297 9143|301950 qHTS Assay for Rab9 Promoter Activators view
663 485298 739|315993 qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion view
664 589 6249|47667 qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region view
665 590 6462|43846 qHTS Assay for Spectroscopic Profiling in A350 Spectral Region view
666 593 537|39192 qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region view
667 596 1408|67382 qHTS Assay for Tau Filament Binding view
668 588795 1366|382229 qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). view
669 485360 1495|217164 qHTS Assay for the Inhibitors of L3MBTL1 view
670 485364 10784|334477 qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins view
671 485367 560|326012 qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase view
672 624202 3980|364019 qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression view
673 624158 805|363362 qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression: Summary view
674 485341 1730|326126 qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) view
675 1688 2384|202328 qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) view
676 1471 306|221646 qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP) view
677 1224872 832|7495 qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour view
678 1224886 1040|7321 qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour view
679 1224868 1149|7196 qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour view
680 1224874 1217|7187 qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour view
681 1224887 632|7862 qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour view
682 1224885 377|8617 qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour view
683 1224867 425|8600 qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour view
684 1224877 443|8627 qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour view
685 1224870 441|8672 qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour view
686 1224873 306|8628 qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour view
687 904 528|50471 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature view
688 903 338|52488 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature view
689 902 1906|118129 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature view
690 924 1163|119907 qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature view
691 743015 2488|6473 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line view
692 743014 2469|6093 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line view
693 743012 2296|6223 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line view
694 504706 201|302703 qHTS assay for re-activators of p53 using a Luc reporter view
695 743209 408|7987 qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen view
696 743202 513|5105 qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway view
697 743203 590|7942 qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen view
698 651631 602|6848 qHTS assay for small molecule agonists of the p53 signaling pathway view
699 651633 748|9015 qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability view
700 720635 1778|4576 qHTS assay for small molecule disruptors of the mitochondrial membrane potential view
701 720634 372|9165 qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability view
702 651632 234|9706 qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 view
703 651634 630|9092 qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability view
704 720516 371|9445 qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary view
705 743083 902|8705 qHTS assay to identify aromatase inhibitors view
706 743084 700|8639 qHTS assay to identify aromatase inhibitors - cell viability counter screen view
707 743139 378|7466 qHTS assay to identify aromatase inhibitors: Summary view
708 1224845 214|7809 qHTS assay to identify small molecule agonists of H2AX view
709 1224847 713|7722 qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen view
710 1159525 353|8559 qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen view
711 1159515 295|7893 qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen view
712 1159529 677|7716 qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen view
713 743040 414|9716 qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway using the MDA cell line view
714 743036 205|8409 qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway view
715 1224839 851|7961 qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway view
716 1224836 493|8335 qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen view
717 1224892 1082|7387 qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary view
718 1159517 327|7657 qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen view
719 743075 559|8983 qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway view
720 743079 1017|7321 qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line view
721 743218 526|7038 qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen view
722 720691 211|9043 qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway view
723 1224844 617|7974 qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen view
724 743211 718|7434 qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen view
725 1159553 428|7226 qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway view
726 1224843 320|7962 qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway view
727 743224 669|7519 qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen view
728 743033 581|8591 qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway - cell viability counter screen view
729 743042 817|8694 qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line view
730 743041 491|8907 qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen view
731 743035 729|6582 qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway view
732 743054 467|7799 qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary view
733 1224838 574|8404 qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway view
734 1224837 522|8324 qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen view
735 743069 432|7863 qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway view
736 743074 374|8134 qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen view
737 743080 472|8192 qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line view
738 743081 369|8842 qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen view
739 743091 472|8192 qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary view
740 743221 381|8042 qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen view
741 720692 402|6501 qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway view
742 720693 448|9032 qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen view
743 743213 536|7031 qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen view
744 743194 522|7425 qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen view
745 1159552 648|7997 qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway view
746 1159555 689|5776 qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary view
747 1159551 254|8653 qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen view
748 1159521 1032|7456 qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway view
749 1159520 497|8312 qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen view
750 1159523 629|5952 qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary view
751 743065 1877|7442 qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway view
752 743064 1421|6973 qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen view
753 743067 419|6971 qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary view
754 743225 452|7381 qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen view
755 1224835 864|8081 qHTS assay to identify small molecule inhibitors of firefly luciferase view
756 743085 786|8524 qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway view
757 743086 465|9005 qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen view
758 743122 1058|7818 qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary view
759 624291 222|332000 qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy view
760 720707 268|363593 qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen view
761 720711 290|363580 qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen view
762 624287 423|302405 qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS view
763 624414 485|404443 qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) view
764 720708 663|357060 qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen view
765 720709 517|353175 qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen view
766 624288 1356|323279 qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS view
767 720542 738|356550 qHTS for Inhibitors of AMA1-RON view
768 651635 3833|345643 qHTS for Inhibitors of ATXN expression view
769 540303 1021|313911 qHTS for Inhibitors of Cell Surface uPA Generation view
770 624170 846|401804 qHTS for Inhibitors of Glutaminase (GLS) view
771 743279 17205|328767 qHTS for Inhibitors of Inflammasome Signaling: IL-1-beta AlphaLISA Primary Screen view
772 720553 3260|336265 qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS view
773 720551 1267|341912 qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS view
774 720504 10204|340947 qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen view
775 588591 4746|373704 qHTS for Inhibitors of Polymerase Eta view
776 588590 4027|358773 qHTS for Inhibitors of Polymerase Iota view
777 588579 2159|396812 qHTS for Inhibitors of Polymerase Kappa view
778 588855 4993|351208 qHTS for Inhibitors of TGF-b view
779 588856 3117|405724 qHTS for Inhibitors of TGF-b: Cytotox Counterscreen view
780 1468 1070|255062 qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization view
781 1460 5823|221865 qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding view
782 602313 765|375193 qHTS for Inhibitors of Vif-A3F Interactions: qHTS view
783 602310 311|398140 qHTS for Inhibitors of Vif-A3G Interactions: qHTS view
784 651768 1678|356304 qHTS for Inhibitors of WRN Helicase view
785 720533 745|14922 qHTS for Inhibitors of binding or entry into cells for Lassa Virus view
786 540256 3679|237268 qHTS for Inhibitors of binding or entry into cells for Lassa Virus view
787 720532 1179|13881 qHTS for Inhibitors of binding or entry into cells for Marburg Virus view
788 686978 64192|243131 qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT view
789 686979 49932|264126 qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT view
790 602179 365|388463 qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS view
791 652105 4081|318633 qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) view
792 493084 651|363975 qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. view
793 493056 2424|362202 qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers view
794 720580 1528|308709 qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS view
795 720579 1941|285391 qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS view
796 686971 7451|328240 qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line view
797 686970 5978|331368 qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line view
798 2551 16819|256756 qHTS for inhibitors of ROR gamma transcriptional activity view
799 540276 5375|212048 qHTS for inhibitors of binding or entry into cells for Marburg Virus view
800 652048 2394|409669 qHTS of D3 Dopamine Receptor Agonist: qHTS view
801 652054 9117|339862 qHTS of D3 Dopamine Receptor Antagonist: qHTS view
802 652051 2394|409669 qHTS of D3 Dopamine Receptor Potentiators: qHTS view
803 624417 6432|321734 qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) view
804 624418 527|389196 qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen view
805 652025 238|364504 qHTS of IL-2 Activators view
806 624171 1243|397872 qHTS of Nrf2 Activators view
807 743266 308|401921 qHTS of PTHR Inhibitors: Primary Screen view
808 652104 7165|371527 qHTS of TDP-43 Inhibitors view
809 624173 493|404612 qHTS of Trypanosoma Brucei Inhibitors view
810 485353 609|322836 qHTS of Yeast-based Assay for SARS-CoV PLP view
811 652106 503|363835 qHTS of alpha-syn Inhibitors view
812 588342 25159|304590 qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) view
813 504466 4174|306923 qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 view
814 504467 7656|235723 qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 view
815 1159537 367|43347 qHTS screening for TAG (triacylglycerol) accumulators in algae view
816 493091 2991|337938 uHTS Colorimetric assay for identification of inhibitors of Scp-1 view
817 602440 2342|361825 uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) view
818 489031 1041|330718 uHTS Fluorescent assay for identification of activators of Apaf-1 view
819 489030 2355|329404 uHTS Fluorescent assay for identification of inhibitors of Apaf-1 view
820 493160 541|340388 uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) view
821 2006 1039|289854 uHTS HTRF assay for identification of inhibitors of SUMOylation view
822 1217 1341|192884 uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays view
823 2524 537|329942 uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase view
824 2805 785|330973 uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase view
825 2825 1296|329183 uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast view
826 2599 5820|324659 uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6) view
827 434973 4906|326852 uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7) view
828 2544 393|330086 uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase view
829 2806 664|331094 uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase view
830 1565 3164|285316 uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1 view
831 1654 1524|289640 uHTS absorbance assay for the identification of compounds that inhibit VHR1. view
832 602141 1309|358211 uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors view
833 1986 891|291591 uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. view
834 2014 2985|285863 uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) view
835 2012 2746|285673 uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) view
836 504462 1735|338616 uHTS fluorescent assay for identification of inhibitors of ATG4B view
837 781 1551|215964 uHTS for 14-3-3/Bad interaction inhibitors view
838 1236 800|217987 uHTS for Calpain Inhibitors view
839 1085 928|217859 uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors view
840 782 801|216714 uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation view
841 485346 10029|321730 uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. view
842 1443 883|216303 uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells view
843 493011 1373|330487 uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay view
844 493012 933|330927 uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay view
845 602244 1305|361082 uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay view
846 624354 3769|360398 uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay view
847 588458 2975|356545 uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay view
848 588413 2509|336051 uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay view
849 624352 2626|361541 uHTS identification of HIF-2a Inhibitors in a luminesence assay view
850 504720 1104|348064 uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay view
851 624304 1795|362372 uHTS identification of SKN-1 Inhibitors in a fluoresence assay view
852 602429 1206|362961 uHTS identification of SUMO1-mediated protein-protein interactions view
853 1012 518|195115 uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay view
854 485273 1540|328070 uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay view
855 588473 1622|347546 uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex view
856 588475 2056|347112 uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex view
857 1496 993|214824 uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay. view
858 1434 1621|216764 uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. view
859 588850 3106|356414 uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay view
860 651647 222|361603 uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay view
861 602399 2821|359566 uHTS identification of inhibitors of NadD in a Colorimetric assay view
862 588493 2136|357384 uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay view
863 651699 2123|362044 uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay view
864 588489 1308|358212 uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay view
865 602438 3086|361081 uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay view
866 651582 1501|225360 uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay view
867 624168 805|363362 uHTS identification of small molecule activators of alpha dystroglycan glycosylation view
868 463104 1101|330658 uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay view
869 449763 1125|330634 uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay view
870 2520 347|330088 uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay view
871 2521 1062|329417 uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay view
872 493098 1656|339273 uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay view
873 651636 2955|361212 uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay view
874 1778 265|290243 uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay view
875 602261 2430|359957 uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay view
876 686954 235|29869 uHTS identification of small molecule inhibitors of Artemis endonuclease activity via a fluorescence intensity assay view
877 651999 1402|362765 uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay view
878 651560 818|363349 uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay view
879 504690 2717|346451 uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay view
880 588621 889|358631 uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay view
881 624204 774|363393 uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay view
882 602449 5040|359127 uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay view
883 463195 4615|327144 uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay view
884 463190 7319|324440 uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay view
885 463212 4406|327353 uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay view
886 588492 2272|357248 uHTS identification of small molecule modulators of myocardial damage view
887 2380 956|329523 uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line view
888 435022 1079|330679 uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation view
889 435003 1736|328743 uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation view
890 1578 3000|286583 uHTS luminescence assay for the identification of compounds that inhibit NOD1 view
891 1566 1839|290646 uHTS luminescence assay for the identification of compounds that inhibit NOD2 view
892 1021 2130|216657 uHTS of Mcl-1/Bid interaction inhibitors view
893 1022 3336|214178 uHTS of Mcl-1/Noxa interaction inhibitors view
894 1274 1145|216493 uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs) view